Phreesia, Inc. (NYSE:PHR) Given Consensus Rating of "Hold" by Brokerages

Key Points

• Phreesia has a consensus “Hold” rating from 19 brokerages: nine rate it a buy, nine a hold and one a sell. The average 12-month price target is $16.65.
• Recent analyst updates were mixed, with Wells Fargo and Barclays maintaining neutral ratings while cutting their price targets to $9 and $10, respectively; DA Davidson retained a $14 buy target.
• Phreesia’s latest quarterly results exceeded expectations, with EPS of $0.05 versus a $0.02 consensus and revenue of $130.94 million, up 12.9% year over year. The stock opened at $12.64, and institutional investors own 92.1% of shares.

Phreesia, Inc. (NYSE:PHR - Get Free Report) has been assigned a consensus recommendation of "Hold" from the nineteen brokerages that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, nine have given a hold rating and nine have issued a buy rating on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $16.6471.

Several brokerages have recently issued reports on PHR. Wells Fargo & Company reiterated an "equal weight" rating and issued a $9.00 target price (down from $15.00) on shares of Phreesia in a research report on Wednesday, May 20th. Weiss Ratings raised shares of Phreesia from a "sell (d)" rating to a "sell (d+)" rating in a research note on Monday, July 20th. Barclays reaffirmed an "equal weight" rating and set a $10.00 target price (down from $24.00) on shares of Phreesia in a report on Thursday, May 14th. DA Davidson reissued a "buy" rating and issued a $14.00 price target on shares of Phreesia in a research note on Thursday, May 28th. Finally, Citigroup restated a "market perform" rating on shares of Phreesia in a research report on Friday, May 29th.

Phreesia Stock Up 3.1%

Shares of PHR opened at $12.64 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.41. Phreesia has a 12 month low of $7.77 and a 12 month high of $32.76. The stock's 50 day moving average is $10.46 and its two-hundred day moving average is $10.61. The firm has a market cap of $781.28 million, a P/E ratio of 84.27 and a beta of 0.85.

Phreesia (NYSE:PHR - Get Free Report) last posted its quarterly earnings data on Wednesday, May 27th. The company reported $0.05 EPS for the quarter, beating analysts' consensus estimates of $0.02 by $0.03. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.The business had revenue of $130.94 million during the quarter, compared to analysts' expectations of $130.08 million. During the same period in the previous year, the business earned ($0.07) earnings per share. The business's revenue was up 12.9% compared to the same quarter last year. Analysts predict that Phreesia will post 0.39 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Raymond James Financial Inc. grew its position in shares of Phreesia by 2.7% in the second quarter. Raymond James Financial Inc. now owns 14,049 shares of the company's stock valued at $400,000 after purchasing an additional 375 shares in the last quarter. Alliancebernstein L.P. increased its stake in shares of Phreesia by 1.3% in the 3rd quarter. Alliancebernstein L.P. now owns 62,712 shares of the company's stock worth $1,475,000 after acquiring an additional 812 shares during the last quarter. Van ECK Associates Corp raised its holdings in shares of Phreesia by 78.7% during the 4th quarter. Van ECK Associates Corp now owns 2,502 shares of the company's stock worth $42,000 after acquiring an additional 1,102 shares during the period. Deutsche Bank AG raised its stake in Phreesia by 2.4% during the fourth quarter. Deutsche Bank AG now owns 66,288 shares of the company's stock worth $1,122,000 after purchasing an additional 1,540 shares during the period. Finally, KBC Group NV raised its position in shares of Phreesia by 83.4% during the 4th quarter. KBC Group NV now owns 3,449 shares of the company's stock valued at $58,000 after buying an additional 1,568 shares during the period. 92.10% of the stock is owned by hedge funds and other institutional investors.

About Phreesia

Phreesia, Inc NYSE: PHR is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company's cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source